Onychomycosis-Tinea-Unguium-Drug-Sales-Market-Report-2017
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
10 <strong>Market</strong>ing Strategy Analysis, Distributors/Traders 91<br />
10.1 <strong>Market</strong>ing Channel 91<br />
10.2 <strong>Market</strong> Positioning 92<br />
10.2.1 <strong>Market</strong> Positioning 92<br />
10.2.2 Brand Strategy 93<br />
10.2.2.1 Introducing pharmaceutical branding strategies 93<br />
10.2.2.2 Building pharmaceutical brands 94<br />
10.2.2.3 Communicating pharmaceutical brands 94<br />
10.2.2.4 Alternative brand models 95<br />
10.2.2.5 The future of pharmaceutical branding 95<br />
10.3 Distributors/Traders List 96<br />
11 <strong>Market</strong> Effect Factors Analysis 98<br />
11.1 Technology 98<br />
11.1.1 Treatment 98<br />
11.1.2 Technology Progress in Related Industry 98<br />
11.2 Consumer Needs/Customer Preference Change 100<br />
11.3 Economic/Political Environmental Change 100<br />
12 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> <strong>Market</strong> Forecast (<strong>2017</strong>-2022) 109<br />
12.1 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) Revenue Forecast (<strong>2017</strong>-2022) 109<br />
12.2 Global <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue and Growth Rate Forecast by Regions<br />
(<strong>2017</strong>-2022) 110<br />
12.2.1 USA <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue and Growth Rate Forecast (<strong>2017</strong>-2022)<br />
112<br />
12.2.2 Europe <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022) 113<br />
12.2.3 China <strong>Onychomycosis</strong> (<strong>Tinea</strong> <strong>Unguium</strong>) <strong>Drug</strong> Revenue and Growth Rate Forecast<br />
(<strong>2017</strong>-2022) 114